PHARMAGEST INTERACTIVE BECOMES HEALTH DATA HOST


Villers-lès-Nancy, 24 January 2012 - 18 :30 (CET)

PRESS RELEASE
For issue immediately

PHARMAGEST INTERACTIVE BECOMES HEALTH DATA HOST 

The PHARMAGEST Group, the French leader in pharmacy information technology, today announces that it has received approval from the Ministry of Work, Employment and Health, as the Host of Health Data of a personal nature (HDS). 

On 4 January 2012, PHARMAGEST INTERACTIVE was approved as Host of Health Data of a personal nature by the Minister for Health. 

Since 2004, safeguarding pharmacists' IT data has been a priority for the Pharmagest Group. 

A forerunner in high technology solutions for the pharmacy, the Pharmagest Group was a pioneer of the secure professional internet. Through its tailor-made, reliable and high-performance services, Pharmagest Interactive has been breaking new ground since 2004, offering its Virtual Private Network " Offisecure", a highly secure system dedicated exclusively to pharmacists, for optimal protection of their electronic exchanges and IT data. 

Due to its approval as Health Data Host for health professionals, from now on, Pharmagest Interactive offers its new outsourced data base back up management service: OffiSafe intended for pharmacists and CareSafe for use by other health professionals and health establishments. 

Outsource backing up with complete security. 
With this approval, today the Pharmagest Group provides health professionals, pharmacists or health establishments, with a service guaranteeing them a strict level of quality, high security and increased performance for all their IT back up problems, and this is in complete compliance with legislation. 

Health professionals, thanks to this product for outsourcing back up of their whole health data base from their professional software but also back up of any type of file containing health data of a personal nature, will be able to guarantee their patients fully secure data handling. Furthermore, coupled with the FAI product "Offisecure" the data will not pass through the public Internet network, for an optimum level of security. 

Obtaining this approval is the result of over a year's work by the Pharmagest Group R & D team. Totally customer-oriented, the Group's policy regarding IT services with high added value owed itself to supplement its product range with an ambitious programme, meeting the security requirements of flows and data. 

This measure is also intended, in terms of organisational and technical development, to guarantee operational service maintenance 24/24, 7/7 in the interests of its customers, pharmacists and health establishments. 

   
The Pharmagest Group:
The PHARMAGEST Group is the French leader in pharmacy information technology, with 43.5% of market share, 9,800 clients and more than 700 staff. Since September 2007, the PHARMAGEST Group has also been enjoying a presence in Northern Europe with 12% market share in Belgium and Luxembourg.

The favoured partner of pharmacists for more than 25 years, the PHARMAGEST Group creates innovative information technology solutions for pharmacies, and develops E-Business E-Media activity with great potential for laboratories.

The PHARMAGEST Group is also developing new software solutions for care homes and day centres for the elderly.

The first Integrated Portal Management Software (LGPI Global Services ®), creating entries for the patient, the pharmacist and the laboratory, boosts sales, optimizes purchases and enhances patient advice. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients. 

Listed on NYSE Euronext Paris(TM) - Compartment C on the CAC SMALL90 and SBF 250 indices by inclusion
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP

Find out the latest news from the PHARMAGEST Group at www.pharmagest.com 

Contacts

Chairman of the Board of Directors: Thierry CHAPUSOT

Managing Director: Dominique PAUTRAT 

Tel. 03 83 15 90 67 - dominique.pautrat@pharmagest.com 

Analyst and Investor Relations: Jean-Yves SAMSON

Tel. 03 83 15 90 67 - jean-yves.samson@pharmagest.com

Press Relations: FIN'EXTENSO Isabelle APRILE 

Tel. 01 39 97 61 22 - i.aprile@finextenso.fr 



Attachments

 PHARMAGEST INTERACTIVE BECOMES HEALTH DATA HOST